Literature DB >> 23267147

HAVcR-1 expression in human colorectal cancer and its effects on colorectal cancer cells in vitro.

Youxin Wang1, Tracey A Martin, Wen G Jiang.   

Abstract

BACKGROUND: Hepatitis A virus cellular receptor 1 (HAVcR-1) may function as part of the regulatory apparatus for tight junction in human endothelial cells, and is overexpressed in renal cell and ovarian clear cell carcinomas.
MATERIALS AND METHODS: HAVcR-1 expression in colorectal cancer and matched background tissues was determined using quantitative-PCR. HAVcR-1 was overexpressed in three colorectal cancer cell lines and the effect of this overexpression was assessed by changes in cell behaviour.
RESULTS: HAVcR-1 expression was increased in colorectal cancer (p<0.001) and the disease-free time of patients with high levels of HAVcR-1 expression was significantly longer (p=0.045). HAVcR-1 overexpression reduced colorectal cancer cell adhesion and invasion (p<0.016).
CONCLUSION: HAVcR-1 overexpression may be a diagnostic biomarker for colorectal cancer and a prognostic marker for a longer disease-free interval after surgery for colorectal cancer. HAVcR-1 overexpression can reduce cell adhesion and invasion and could thus be involved in the metastatic cascade.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23267147

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Tissue Expression of Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 in Breast Cancers.

Authors:  Gülden Diniz; Ayşe Gül Pulular; Dudu Solakoğlu Kahraman; Umut Varol; Sevil Sayhan; Duygu Ayaz; Cem Karaali
Journal:  Eur J Breast Health       Date:  2022-10-01

2.  Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia.

Authors:  Seong Gu Heo; Youngil Koh; Jong Kwang Kim; Jongsun Jung; Hyung-Lae Kim; Sung-Soo Yoon; Ji Wan Park
Journal:  BMC Med Genet       Date:  2017-03-01       Impact factor: 2.103

3.  Prognostic value of TIM-1 expression in human non-small-cell lung cancer.

Authors:  Xiao Zheng; Kai Xu; Lujun Chen; You Zhou; Jingting Jiang
Journal:  J Transl Med       Date:  2019-05-28       Impact factor: 5.531

4.  Hepatitis A Virus Cellular Receptor 1 (HAVcr-1) Initiates Prostate Cancer Progression in Human Cells via Hepatocyte Growth Factor (HGF)-Induced Changes in Junctional Integrity.

Authors:  Emily A Telford; Andrew J Sanders; Sioned Owen; Fiona Ruge; Gregory M Harrison; Wen G Jiang; Tracey A Martin
Journal:  Biomolecules       Date:  2022-02-21

5.  Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma.

Authors:  Xiao-Ren Zhu; Jia-Qi Zhu; Yu-Fei Chen; Yuan-Yuan Liu; Jing-Jing Lu; Jun Sun; Shi-Qing Peng; Min-Bin Chen; Yi-Ping Du
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

6.  A plasma-derived extracellular vesicle mRNA classifier for the detection of breast cancer.

Authors:  Geng-Xi Cai; Li Lin; Xiang-Ming Zhai; Zhi-Wei Guo; Ying-Song Wu; Guo-Lin Ye; Qing Liu; Lu-Shi Chen; Guan-Yu Xing; Qiao-Hong Zhao; Li-Ling Tang; Shun-He Mai; Bo-Jian Ye
Journal:  Gland Surg       Date:  2021-06

7.  HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome.

Authors:  Ji Xue; Ying Li; Jianfeng Yi; Hong Jiang
Journal:  Gastroenterol Res Pract       Date:  2019-12-02       Impact factor: 2.260

Review 8.  Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review).

Authors:  Т А Karmakova; N S Sergeeva; К Yu Kanukoev; B Ya Alekseev; А D Kaprin
Journal:  Sovrem Tekhnologii Med       Date:  2021-06-28

9.  Long non-coding RNA AL139002.1 promotes gastric cancer development by sponging microRNA-490-3p to regulate Hepatitis A Virus Cellular Receptor 1 expression.

Authors:  Yurong Chen; Renchao Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.